MARKET COMMENTARY ON INNOCAN PHARMA, AN UP-AND-COMING LEADER IN CBD VETERINARY SOLUTIONS

PESG Research, a brand under the Future Markets Research Tank (FMRT), is proud to release market commentary on Innocan Pharma, an up-and-coming leader in the CBD veterinary solutions Industry.

PESG Comment:
“It’s well-established that CBD holds immense potential as a therapeutic ingredient, hence given its low bioavailability and rapid degradation in the liver it is yet to be administered to humans as a drug. As the market evolves towards commercialization of cannabinoids as Active Pharmaceutical Ingredients, we covered several leading companies in the field, with an emphasis on Innocan Pharma. We hope that the information presented will assist in assessing the risks and opportunities of the field”.

Read the Report

Disclaimer: The author(s)/brand(s) is compensated to provide independent analysis of companies. The stock market is volatile and investors are advised to do their own research prior to making a decision. Market commentary is individual opinion and should not serve as any form of advice. You must always do your own research. "Future Markets Research Tank" and any pseudonyms or brands or accounts associated with it are digital brand names and do not seek to be any form of financial advisor or equity research organization. We may operate under a number of pseudonyms. We received monetary compensation for  the content and thoughts presented above and that should be taken into account when reading any content presented. Do Not Use Any Information in Our Publications, social media channels or anything else associate with our brand to Make an Investment Decision. There is no information on our website or distributed otherwise that should be used as the basis for an investment decision. We do not act, directly or indirectly, in the capacity of any of the following and you should not construe our activities as involving any of the following: (a) investment advisor; (b) broker dealer; (c) broker; (d) dealer; (e) stock recommender; (f) stock picker; (g) finder; (h) securities trading expert; (i) financial planner; (j) engaging in the offer and sale of securities; (k) securities analyst; (l) financial analyst; (m) providing price targets or buy or sell recommendations. Our activities involve multiple potential and/or actual conflicts of interest - we receive monetary or securities compensation in the very securities we are promoting. The third party shareholder from which we receive compensation also has an actual conflict of interest since he or she or it is paying us securities compensation for promotion services and such non-affiliate third party shareholder may sell other shares held while we are promoting the issuer that issues the stock held by such third party shareholder. There are no implied or express warranties regarding the contents of our Publications.

© Pharma & ESG Sustainability Group (PESG), all rights reserved.
A brand associated with the Future Market Research Tank

DISCLAIMERSFollow us On Twitter

Disclaimer: The author(s)/brand(s) is compensated to provide independent analysis of companies. The stock market is volatile and investors are advised to do their own research prior to making a decision. Market commentary is individual opinion and should not serve as any form of advice. You must always do your own research. "Future Markets Research Tank" and any people/brands associated with it are digital brand names and do not seek to be any form of financial advisor or equity research organization. We received monetary compensation for  the content and thoughts presented above and that should be taken into account when reading any content presented. Do Not Use Any Information in Our Publications, social media channels or anything else associate with our brand to Make an Investment Decision. There is no information on our website or distributed otherwise that should be used as the basis for an investment decision. We do not act, directly or indirectly, in the capacity of any of the following and you should not construe our activities as involving any of the following: (a) investment advisor; (b) broker dealer; (c) broker; (d) dealer; (e) stock recommender; (f) stock picker; (g) finder; (h) securities trading expert; (i) financial planner; (j) engaging in the offer and sale of securities; (k) securities analyst; (l) financial analyst; (m) providing price targets or buy or sell recommendations. Our activities involve multiple potential and/or actual conflicts of interest - we receive monetary or securities compensation in the very securities we are promoting. The third party shareholder from which we receive compensation also has an actual conflict of interest since he or she or it is paying us securities compensation for promotion services and such non-affiliate third party shareholder may sell other shares held while we are promoting the issuer that issues the stock held by such third party shareholder. There are no implied or express warranties regarding the contents of our Publications.